Loading Events

« All Events

  • This event has passed.

PF Warrior Special Clinical Trial Meeting: BEACON-IPF

September 30 @ 10:00 am 11:30 am CDT

PF Warriors is excited to invite you to a special Zoom clinical trial presentation. Join us to learn about BEACON-IPF, a global 2b clinical trial to evaluate the investigational drug bexotegrast for the treatment of idiopathic pulmonary fibrosis (IPF).

Whether you are new to clinical trials or have prior experience, this presentation will provide valuable insights into the future treatment options for pulmonary fibrosis (PF). Join Dr. Gregory Cosgrove, MD, FCCP as he discusses how you can contribute to advancing treatment options for PF.

Topics to be discussed:

  • 🔹 Introduction to Pliant Therapeutics 
  • 🔹 Brief review of data from prior studies with bexotegrast
  • 🔹 Review of BEACON-IPF Study, who is qualified to participate, and how to find a study site

Learn more about Gregory Cosgrove, MD, FCCP.

Special Clinical Trial Meeting Image including a photo of Dr. Gregory Cosgrove.
Free

PF Warriors

Zoom

Become a PF Warriors Member!

Membership is always FREE! By becoming a member of the PF Warriors community, you will gain exclusive access to incredible resources designed to support and empower you on your journey with pulmonary fibrosis. 

As a member, you will:

  • 🔹 Receive advance notifications of upcoming meetings, webinars and events so you never miss out on important discussions like this one.
  • 🔹 Get full access to over 100 recorded meetings featuring expert presentations on everything from treatment options and research breakthroughs to lifestyle tips and emotional support, helping you live your best life with pulmonary fibrosis. 
  • 🔹 Join for FREE! Signing up is quick and easy, and you’ll instantly become part of a supportive network of fellow patients, caregivers, and medical professionals.

Join PF Warriors Website


What is Pulmonary Fibrosis? 

Pulmonary fibrosis is a progressive lung disorder characterized by the formation of scar tissue in the lungs. This scarring leads to breathing difficulties, diminished lung function, and lower oxygen levels in the bloodstream..